期刊文献+

心脉隆注射液对冠心病心力衰竭患者BNP、尿酸的影响 被引量:8

下载PDF
导出
摘要 目的观察心脉隆注射液对冠心病心力衰竭患者心功能、B型利钠肽(BNP)、尿酸(UA)的影响。方法将住院治疗的冠心病心力衰竭患者67例随机分为两组,对照组采用常规药物治疗,治疗组在常规治疗基础上加用心脉隆注射液5mg/kg+5%葡萄糖200mL静脉输注,每天2次,5d为1个疗程。2个疗程结束时比较疗效及BNP、UA水平。结果治疗2个疗程后,治疗组疗效优于对照组,而BNP及UA水平低于对照组,差异有统计学意义(P<0.05)。结论心脉隆注射液可改善冠心病心力衰竭患者心功能,降低BNP及UA水平。
出处 《中西医结合心脑血管病杂志》 2015年第6期829-830,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献12

二级参考文献48

  • 1陈章强,洪浪,王洪,尹秋林,周裔忠,赖珩莉,李华泰,王晓华.慢性心力衰竭患者血清尿酸水平的变化及其临床意义[J].江西医药,2006,41(7):480-481. 被引量:7
  • 22009 focus update:ACCF/AHA guideline for the diagnosis and management of heart failure in adults [ J ]. Circulation, 2009, 119 : e391.
  • 3Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guideline for the diagnosis and treatment of acute and chronic heart failure 2008 : The Task Force for the Diagnosis and Treardiology. Developed in collaboration with HFAand endorsed by(ESIM) [J]. Eur Heart J, 2008, 29(19) : 2388.
  • 4Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronm7 arterv disease and left-ventricular systolic dysfunction ( BEAUTIFUL) : a suhglmalysis of a randomised controlled trial[ J]. Lancet, 2008, 372(9641) : 817-821.
  • 5Swedberg K, K,,majda M, Bahm M, et al. Ivabradine and outcomes in chronic heart failure ( SHIFT ) : a randomised placebo-controlled study [ J ]. Lancet, 2010, 376(9744) : 875-885.
  • 6McMurray JJ, Swedberg K. HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure-lessons learnt from a decade of trials[ J]. Eur J Heart Fail, 2010, 12(2) : 99-103.
  • 7Danbert C, Gold MR, Abraham WT, et ah Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction : insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial[J]. J Am Coil Cardiol, 2009, 54(20) : 1837-1846.
  • 8Chan D, Ng LL. Biomarkers in acute myocardial infarction[J]. BMC Med, 2010,8:34-45.
  • 9Nakayama T. The genetic contlibution of the natriuretic peptide system to cardiovascular diseases[J]. Endocr J, 2005,52:11-21.
  • 10Daniels LB, Maisel AS. Natriuretic peptides[ J]. J Am Call Cardiol,2007,50: 2357-2368.

共引文献176

同被引文献91

引证文献8

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部